Acta Haematologica · 2009 · 16 citations · 0 references
MedicineHematologyPharmacologyChemotherapyClinical ImmunologyHematologic OncologyChemotherapy In Hematologic MalignanciesHematologic MalignanciesHematologic ToxicityMultiple SclerosisAcute Leukemias
A case of acute myeloblastic leukaemia is reported in a patient treated with chlorambucil during 72 months for multiple sclerosis. In a review of the medical literature, 43 additional reports of acute leukaemia after chlorambucil therapy for non-malignant diseases were found. Most cases are of a non-lymphoid type and preceded by various blood and bone marrow abnormalities. The prognosis is poor with a short survival. The risk of developing acute leukaemia after long-term immunosuppressive treatment with chlorambucil is emphasized.